Antihypertensive Agents

"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Descriptor ID	D000959
MeSH Number(s)	D27.505.954.411.162
Concept/Terms	Antihypertensive Agents Antihypertensive Agents Agents, Antihypertensive Antihypertensives Anti-Hypertensives Anti Hypertensives Antihypertensive Drugs Drugs, Antihypertensive Anti-Hypertensive Agents Agents, Anti-Hypertensive Anti Hypertensive Agents Anti-Hypertensive Drugs Anti Hypertensive Drugs Drugs, Anti-Hypertensive

Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Antihypertensive Agents [D27.505.954.411.162]

Below are MeSH descriptors whose meaning is related to "Antihypertensive Agents".

Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.

Bar chart showing 248 publications over 28 distinct years, with a maximum of 22 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	3	0	3
1997	2	0	2
1998	2	1	3
1999	5	0	5
2001	4	0	4
2002	1	1	2
2003	5	9	14
2004	1	4	5
2005	5	1	6
2006	8	1	9
2007	8	5	13
2008	11	6	17
2009	12	10	22
2010	5	5	10
2011	9	3	12
2012	7	3	10
2013	8	2	10
2014	10	2	12
2015	9	1	10
2016	6	5	11
2017	6	4	10
2018	10	2	12
2019	12	3	15
2020	9	5	14
2021	3	4	7
2022	1	2	3
2023	1	4	5
2024	2	0	2

Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.

Akinyelure OP, Jaeger BC, Safford MM, Oparil S, Carson AP, Sims A, Hannon L, Howard G, Muntner P, Hardy ST. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study. J Am Heart Assoc. 2024 May 21; 13(10):e031695.

View in: PubMed
Maykin MM, Mercer E, Saiki KM, Kaneshiro B, Miller CB, Tsai PS. Furosemide to lower antenatal severe hypertension: a randomized placebo-controlled trial. Am J Obstet Gynecol MFM. 2024 04; 6(4):101348.

View in: PubMed
Yaacoub S, Boudaka A, AlKhatib A, Pintus G, Sahebkar A, Kobeissy F, Eid AH. The pharmaco-epigenetics of hypertension: a focus on microRNA. Mol Cell Biochem. 2024 Dec; 479(12):3255-3271.

View in: PubMed
Rice B, Mbatidde L, Oluleye O, Onwuanyi A, Adedinsewo D. Managing hypertension in African Americans with heart failure: A guide for the primary care clinician. J Natl Med Assoc. 2024 Oct; 116(5):477-489.

View in: PubMed
Bolin LP, Crane PB, Gunn LH. Exploring Cytokine Networks in Resistant Hypertension. Nurs Res. 2024 Jan-Feb 01; 73(1):16-25.

View in: PubMed
Drawz PE, Lenoir KM, Rai NK, Rastogi A, Chu CD, Rahbari-Oskoui FF, Whelton PK, Thomas G, McWilliams A, Agarwal AK, Suarez MM, Dobre M, Powell J, Rocco MV, Lash JP, Oparil S, Raj DS, Dwyer JP, Rahman M, Soman S, Townsend RR, Pemu P, Horwitz E, Ix JH, Tuot DS, Ishani A, Pajewski NM. Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT. Clin J Am Soc Nephrol. 2024 Feb 01; 19(2):213-223.

View in: PubMed
Hardy ST, Hannon L, Hall L, Cherrington AL. Design of the Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical Activity Study: A Cluster Randomized Trial. Am J Hypertens. 2023 04 15; 36(5):248-255.

View in: PubMed
Han KD, Hwang Y, Park SH. Blood pressure status affects atrial fibrillation in diabetic end-stage renal disease. PLoS One. 2023; 18(4):e0283875.

View in: PubMed
Matanes F, Siddiqui M, Velasco A, Sharifov O, Kreps E, Dudenbostel T, Judd EK, Zhang B, Lloyd SG, Oparil S, Calhoun DA. Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension. J Clin Hypertens (Greenwich). 2023 05; 25(5):416-425.

View in: PubMed
Singer AG, LaBine L, Katz A, Yogendran M, Lix L. Primary medication nonadherence in a large primary care population: Observational study from Manitoba. Can Fam Physician. 2022 07; 68(7):520-527.

View in: PubMed

People

Explore

Similar Concepts

Top Journals